Patients Don't Remember What Their Doctors Tell Them

OncologyONCOLOGY Vol 11 No 5
Volume 11
Issue 5

Mayo Clinic study of patient-physician communication found that patients frequently do not remember what their doctor tells them.

Mayo Clinic study of patient-physician communication found that patientsfrequently do not remember what their doctor tells them.

The study, reported in the December issue of Mayo Clinic Proceedings,focused on the results of general medical examinations given to 566 communitypatients. Researchers collected information from both patients and physiciansabout health problems and cardiac risk factors uncovered in the examinations.They found that patients, surveyed at home after the examination, did notmention 68% of health problems diagnosed by their physician, including54% of their most important diagnosed health problems. Some of the mostfrequently diagnosed health problems not reported by patients included:hypothyroidism, colorectal polyps, obesity, osteoarthritis, and tobaccoabuse.

Study author Dr. Sidna Scheitel believes that the low level of agreementbetween physician and patients is due to a number of factors--misunderstandingof medical terminology used by doctors; "selective listening";and denial of the presence of health issues, such as obesity and tobaccouse. Also, patients and physicians may differ in their perception of theimportance of a health problem.

The survey found that patients who had received a new diagnosis or diagnosisof a major health problem and patients who traveled a considerable distancefor their care were most likely to remember and follow what their doctorhad discussed with them.

Dr. Scheitel says the study suggests that doctors should consider givingproblem lists or summary letters to patients to improve and reinforce thecommunication and management of health problems.

Related Videos
Experts on RCC
Experts on RCC
Experts on multiple myeloma
Experts on multiple myeloma
An expert from Weill Cornell Medicine highlights key clinical data indicating the benefits of radium-223 in the treatment of patients with metastatic castration-resistant prostate cancer.
Experts on GVHD with a patient
Experts on breast cancer
Experts on GVHD with a patient
Experts on breast cancer
The risk of radionuclide exposure to the public reflects one reason urologists need to collaborate with radiation oncologists when administering radiopharmaceuticals to patients with prostate cancer.
Related Content